C4 Therapeutics's total assets for Q3 2025 were $265.49M, a decrease of -10.47% from the previous quarter. CCCC total liabilities were $111.08M for the fiscal quarter, a -9.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.